NDC 0378-0160

Methyclothiazide

Methyclothiazide

Methyclothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Methyclothiazide.

• Product ID: 0378-0160_41d6b92e-b9f4-4bcf-9f66-9a36c8e79181
• NDC: 0378-0160
• Product Type: Human Prescription Drug
• Proprietary Name: Methyclothiazide
• Generic Name: Methyclothiazide
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 1982-08-17
• Marketing End Date: 2019-12-31
• Marketing Category: ANDA / ANDA
• Application Number: ANDA087672
• Labeler Name: Mylan Pharmaceuticals Inc.
• Substance Name: METHYCLOTHIAZIDE
• Active Ingredient Strength: 5 mg/1
• Pharm Classes: Thiazide Diuretic [EPC],Thiazides [CS],Increased Diuresis [PE]
• NDC Exclude Flag: N

Packaging

NDC 0378-0160-01

100 TABLET in 1 BOTTLE (0378-0160-01)

• Marketing Start Date: 1982-08-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0378-0160-01 [00378016001]

Methyclothiazide TABLET

• Marketing Category: ANDA
• Application Number: ANDA087672
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1982-08-17
• Marketing End Date: 2019-12-31

Drug Details

Active Ingredients

Ingredient	Strength
METHYCLOTHIAZIDE	5 mg/1

OpenFDA Data

• SPL SET ID: 4910dad2-c533-4232-85bf-e6b0235379c2
• Manufacturer:
  • Mylan Pharmaceuticals Inc.
• UNII:
  • L3H46UAC61
• RxNorm Concept Unique ID - RxCUI:
  • 197951

Pharmacological Class

• Thiazide Diuretic [EPC]
• Thiazides [CS]
• Increased Diuresis [PE]